1. Yoder JS, Beach MJ. Cryptosporidiosis surveillance – United States, 2003–2005. Morbidity and Mortality Weekly Report 2007; 54: 1–10.
2. Dillingham RA, Lima AA, Guerrant RL. Cryptosporidiosis: epidemiology and impact. Microbes and Infection 2002; 4: 1059–1066.
3. Centers for Disease Control and Prevention. Cryptosporidiosis outbreaks associated with recreational water use – five states, 2006. Morbidity and Mortality Weekly Report 2007; 56: 729–732.
4. Korich DG, et al. Effects of ozone, chlorine dioxide, chlorine, and monochloramine on Cryptosporidium parvum oocyst viability. Applied and Environmental Microbiology 1990; 56: 1423–1428.
5. Dziuban EJ, et al. Surveillance for waterborne disease and outbreaks associated with recreational water – United States, 2003–2004. Morbidity and Mortality Weekly Report 2006; 55: 1–30.
6. Fox LM, Saravolatz LD. Nitazoxanide: a new thiazolide antiparasitic agent. Clinical Infectious Diseases 2005; 40: 1173–1180.
8. Xiao L, et al. Cryptosporidium taxonomy: recent advances and implications for public health. Clinical Microbiology Reviews 2004; 17: 72–97.
9. Bukhari Z, et al. Medium-pressure UV for oocyst inactivation. Journal of the American Water Works Association 1999; 91: 86–94.
10. Rochelle PA, et al. The response of Cryptosporidium parvum to UV light. Trends in Parasitology 2005; 21: 81–87.
11. MacKenzie WR, et al. A massive outbreak in Milwaukee of Cryptosporidium infection transmitted through the public water supply. New England Journal of Medicine 1994; 331: 161–167.
12. Wheeler C, et al. Outbreak of cryptosporidiosis at a California waterpark: employee and patron roles and the long road towards prevention. Epidemiology and Infection 2007; 135: 302–310.
13. Insulander M, et al. An outbreak of cryptosporidiosis associated with exposure to swimming pool water. Scandinavian Journal of Infectious Diseases 2005; 37: 354–360.
14. MacKenzie WR, et al. Massive outbreak of waterborne cryptosporidium infection in Milwaukee, Wisconsin: recurrence of illness and risk of secondary transmission. Clinical Infectious Diseases 1995; 21: 57–62.
15. Weir SC, et al. Efficacy of common laboratory disinfectants on the infectivity of Cryptosporidium parvum oocysts in cell culture. Applied and Environmental Microbiology 2002; 68: 2576–2579.
16. Rossignol JFA, Ayoub A, Ayers MS. Treatment of diarrhea caused by Cryptosporidium parvum: a prospective randomized, double-blind, placebo-controlled study of nitazoxanide. Journal of Infectious Diseases 2001; 184: 103–106.
17. Rossignol JFA, et al. Effect of nitazoxanide in diarrhea and enteritis caused by Cryptosporidium species. Clinical Gastroenterology and Hepatology 2006; 4: 320–324.